title: Genetic variations of NAT2 and CYP2E1 and isoniazid hepatotoxicity in a diverse population.
authors.forename: Virginia
authors.initials: V
authors.lastname: Leiro-Fernandez
authors.forename: Diana
authors.initials: D
authors.lastname: Valverde
authors.forename: Rafael
authors.initials: R
authors.lastname: Vázquez-Gallardo
authors.forename: Lucía
authors.initials: L
authors.lastname: Constenla
authors.forename: Alberto
authors.initials: A
authors.lastname: Fernández-Villar
mesh_terms: D000483:Alleles; D000995:Antitubercular Agents / Q000009:adverse effects*; D001191:Arylamine N-Acetyltransferase / Q000097:blood*; D016022:Case-Control Studies; D056486:Chemical and Drug Induced Liver Injury / Q000235:genetics*; D019392:Cytochrome P-450 CYP2E1 / Q000235:genetics*; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D011110:Polymorphism, Genetic; D018401:Sample Size
chemical_list: D000995:Antitubercular Agents; D019392:Cytochrome P-450 CYP2E1; D001191:Arylamine N-Acetyltransferase; C478900:NAT2 protein, human